106 related articles for article (PubMed ID: 1998848)
21. Femoropopliteal prosthetic bypass with glutaraldehyde stabilized human umbilical vein (HUV).
Neufang A; Espinola-Klein C; Dorweiler B; Messow CM; Schmiedt W; Vahl CF
J Vasc Surg; 2007 Aug; 46(2):280-8. PubMed ID: 17600663
[TBL] [Abstract][Full Text] [Related]
22. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
Lumsden AB; Morrissey NJ;
J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
[TBL] [Abstract][Full Text] [Related]
23. A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosis.
Jayson MI; Holland CD; Keegan A; Illingworth K; Taylor L
Ann Rheum Dis; 1991 Jan; 50(1):41-7. PubMed ID: 1994867
[TBL] [Abstract][Full Text] [Related]
24. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
Rychlik IJ; Davey P; Murphy J; O'Donnell ME
J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
[TBL] [Abstract][Full Text] [Related]
25. Deficient fibrinolysis associated with rapidly progressive arterial disease.
Barrie WW
Br J Surg; 1974 Sep; 61(9):718-20. PubMed ID: 4278049
[No Abstract] [Full Text] [Related]
26. Femoral-popliteal bypass with endoscopically harvested saphenous vein in patients with TASC D disease of the superficial femoral artery.
Hines GL; Wain RA; Montecalvo J; Feuerman M
Ann Vasc Surg; 2010 Jul; 24(5):615-20. PubMed ID: 19892513
[TBL] [Abstract][Full Text] [Related]
27. Venous lipodermatosclerosis: treatment by fibrinolytic enhancement and elastic compression.
Burnand K; Clemenson G; Morland M; Jarrett PE; Browse NL
Br Med J; 1980 Jan; 280(6206):7-11. PubMed ID: 6986945
[TBL] [Abstract][Full Text] [Related]
28. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency.
Chesebro JH; Clements IP; Fuster V; Elveback LR; Smith HC; Bardsley WT; Frye RL; Holmes DR; Vlietstra RE; Pluth JR; Wallace RB; Puga FJ; Orszulak TA; Piehler JM; Schaff HV; Danielson GK
N Engl J Med; 1982 Jul; 307(2):73-8. PubMed ID: 7045659
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of fibrinolytic enhancement with stanozolol in the treatment of venous insufficiency.
McMullin GM; Watkin GT; Coleridge Smith PD; Scurr JH
Aust N Z J Surg; 1991 Apr; 61(4):306-9. PubMed ID: 2018441
[TBL] [Abstract][Full Text] [Related]
30. The influence of anesthetic method on infrainguinal bypass graft patency: a closer look.
Perler BA; Christopherson R; Rosenfeld BA; Norris EJ; Frank S; Beattie C; Williams GM
Am Surg; 1995 Sep; 61(9):784-9. PubMed ID: 7661476
[TBL] [Abstract][Full Text] [Related]
31. Defective fibrinolysis: a risk factor in early femoropopliteal graft thrombosis.
Earnshaw JJ; Westby JC; Makin GS; Hopkinson BR
Br J Surg; 1987 Oct; 74(10):932-5. PubMed ID: 3664225
[TBL] [Abstract][Full Text] [Related]
32. Outcome of the FUSION vascular graft for above-knee femoropopliteal bypass.
Assadian A; Eckstein HH;
J Vasc Surg; 2015 Mar; 61(3):713-9.e1. PubMed ID: 25498193
[TBL] [Abstract][Full Text] [Related]
33. The efficacy of dextran 40 in preventing early postoperative thrombosis following difficult lower extremity bypass.
Rutherford RB; Jones DN; Bergentz SE; Bergqvist D; Karmody AM; Dardik H; Moore WS; Goldstone J; Flinn WR; Comerota AJ
J Vasc Surg; 1984 Nov; 1(6):765-73. PubMed ID: 6208387
[TBL] [Abstract][Full Text] [Related]
34. Successful thrombolytic therapy for acute and chronic occlusion of polytef vascular grafts.
Bisig CJ; Kerstein MD
Arch Surg; 1983 Oct; 118(10):1218-20. PubMed ID: 6615205
[TBL] [Abstract][Full Text] [Related]
35. [Factors determining late patency of aortobifemoral bypass graft].
Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
[TBL] [Abstract][Full Text] [Related]
36. The Debatable Choice of Iliac Inflow Source for Redo Femoropopliteal and Infrapopliteal Bypass.
Gabrielli R; Ciocca F; Dante A; Musilli A; Maiorano M; Ventura M
Ann Vasc Surg; 2018 Oct; 52():316.e15-316.e19. PubMed ID: 29886210
[TBL] [Abstract][Full Text] [Related]
37. Fibrinolytic enhancement by stanozolol: a double-blind trial.
Davidson JF; McDonald GA; McNicol GP
J Clin Pathol; 1972 Jul; 25(7):639. PubMed ID: 4560843
[No Abstract] [Full Text] [Related]
38. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Hohman S; Pearl G; Theune B
J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
[TBL] [Abstract][Full Text] [Related]
39. Autologus saphenous vein femoropopliteal bypass: analysis of 298 cases.
Cutler BS; Thompson JE; Kleinsasser LJ; Hempel GK
Surgery; 1976 Mar; 79(3):325-31. PubMed ID: 1257898
[TBL] [Abstract][Full Text] [Related]
40. [Reoperations for early thromboses of femoropopliteal and tibial artery bypass. Apropos of 50 cases].
Peillon C; Laissy JP; Didelon JL; Watelet J; Testart J
J Chir (Paris); 1988 Jan; 125(1):4-12. PubMed ID: 3350868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
